An adverse reaction to buprenorphine/naloxone induction in prison: A case report

Josiah D. Rich, Michelle McKenzie, Samuel Dickman, Jeffrey Bratberg, Joshua D. Lee, Robert P. Schwartz

Research output: Contribution to journalArticlepeer-review

Abstract

Buprenorphine is an effective treatment for opiate dependence. Prisoners with histories of opiate dependence who are inducted on buprenorphine prior to release are at decreased risk of post-release relapse and overdose, yet many clinicians are unaware of the risks related to buprenorphine induction for non-opiate tolerant patients, especially those on other psychotropic medications. The authors report a case of probable non-lethal overdose during dose induction of a non-tolerant prisoner and discuss appropriate dosing under similar circumstances.

Original languageEnglish (US)
Pages (from-to)199-200
Number of pages2
JournalAddictive Disorders and their Treatment
Volume10
Issue number4
DOIs
StatePublished - Dec 2011

Keywords

  • Words: buprenorphine
  • adverse event
  • naloxone
  • opiate addiction
  • prison

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'An adverse reaction to buprenorphine/naloxone induction in prison: A case report'. Together they form a unique fingerprint.

Cite this